CRYAB and systemic lupus erythematosus: Thus, we demonstrated via two independent studies and two different preclinical efficacy models that HSPB5 intercepts splenic monocyte/macrophage-dependent inflammatory responses and T effector cells before they are mobilized into the kidneys of lupus-prone mice.